Lack of association between interleukin-22 gene polymorphisms and cancer risk: a case –control study and a meta-analysis

ConclusionConsequently, the rs1179251, rs2227485, rs2227511, and rs2227473 polymorphisms may not be associated with cancer risk. However, further investigations using larger samples in different ethnic populations are required.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research